Filgrastim - PDFSEARCH.IO - Document Search Engine

Filgrastim
Results: 93

#	Item
61	RÉGIMES DE MÉDICAMENTS DU NOUVEAU-BRUNSWICK FILGRASTIM (NEUPOGENMD) / PEGFILGRASTIM (NEULASTAMD) FORMULAIRE DE DEMANDE D’AUTORISATION SPÉCIALE New Brunswick Drug Plans / Régimes de médicaments du Nouveau-Brunswi Add to Reading List Source URL: www.gnb.ca Language: French - Date: 2014-07-08 13:06:17
62	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ELAPRASE safely and effectively. See full prescribing information for ELAPRASE. ------------------DOSAGE FORMS AND S Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-06-25 09:23:40 Immunosuppressants Hunter syndrome Syndromes Piperazines Urticaria Anakinra Filgrastim Medicine Immunology Health
63	NEW BRUNSWICK DRUG PLANS FILGRASTIM (NEUPOGEN®) /PEGFILGRASTIM (NEULASTA®) SPECIAL AUTHORIZATION REQUEST FORM New Brunswick Drug Plans / Régimes de médicaments du Nouveau-Brunswick Add to Reading List Source URL: www.gnb.ca Language: English - Date: 2014-07-08 13:06:17 Growth factors Pegfilgrastim Hematology Filgrastim Chemotherapy Methadone New Brunswick Medicine Biology Amgen
64	Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl Add to Reading List Source URL: www.pmda.go.jp Language: English - Date: 2014-06-04 01:05:55 Growth factors Neutropenia Hematopathology Oncology Hematopoietic stem cell transplantation Filgrastim Aplastic anemia Myelodysplastic syndrome Chemotherapy Medicine Hematology Amgen
65	Rapporteur’s Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Add to Reading List Source URL: www.hma.eu Language: English - Date: 2010-07-01 10:53:41 Hematology Amgen Cytokines Filgrastim Granulocyte colony-stimulating factor Hematopoietic stem cell transplantation Chemotherapy Center for International Blood and Marrow Transplant Research Neutropenia Medicine Biology Growth factors
66	NEUPOGEN® (filgrastim) DESCRIPTION Filgrastim is a human granulocyte colony-stimulating factor (G-CSF)‚ produced by ® recombinant DNA technology. NEUPOGEN is the Amgen Inc. trademark for filgrastim‚ which has been Add to Reading List Source URL: patentdocs.typepad.com Language: English - Date: 2014-07-29 01:16:49 Growth factors Hematology Filgrastim Oncology Cytokines Medicine Biology Amgen
67	Microsoft PowerPoint - ASCT0631 FDA presentation grupp.ppt Add to Reading List Source URL: www.fda.gov Language: English - Date: 2008-12-16 15:53:27 Transplantation medicine Amgen Growth factors Stem cells Hematopoietic stem cell transplantation Granulocyte colony-stimulating factor Graft-versus-host disease Apheresis Filgrastim Medicine Biology Hematology
68	FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and the Oncologic Drugs Advisory Committee (ODAC) FDA White Oak Campus, Building Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Amgen Growth factors Therapeutics United States Public Health Service Filgrastim Center for Drug Evaluation and Research National Institute of Allergy and Infectious Diseases Pegfilgrastim Food and Drug Administration Pharmacology Medicine
69	FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and the Oncologic Drugs Advisory Committee (ODAC) FDA White Oak Campus, Building Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Amgen Growth factors Therapeutics United States Public Health Service Filgrastim Center for Drug Evaluation and Research National Institute of Allergy and Infectious Diseases Pegfilgrastim Food and Drug Administration Pharmacology Medicine
70	NEUPOGEN® (filgrastim) DESCRIPTION Filgrastim is a human granulocyte colony-stimulating factor (G-CSF)‚ produced by recombinant DNA technology. NEUPOGEN® is the Amgen Inc. trademark for filgrastim‚ which has been s Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-09-17 10:57:16 Growth factors Hematology Filgrastim Oncology Cytokines Medicine Biology Amgen

UPDATE